Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Finasteride vs Rye Pollen Extract: Finasteride has the stronger overall evidence (5.5 vs 4.8/10); they're alternatives for prostate health — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Finasteride wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Finasteride and Rye Pollen Extract have evidence — compare verdict strength side-by-side.
1 mg once daily for male pattern hair loss (Propecia); 5 mg once daily for benign prostatic hyperplasia (Proscar). A prescription drug — use under a clinician.
any
Oral tablet (1 mg for hair, 5 mg for BPH)
2 capsules/tablets three times daily (every 8 hours), or 375-750 mg twice daily
Three divided doses per day, roughly every 8 hours, With or without food — no trial specified a meal requirement
Cernilton / Cernitin standardized rye-grass pollen extract
3-12 months to visible effect
Months to years
Throughout use; sometimes persistent
Throughout use
12-24 weeks
12-24 weeks
6-12 weeks
6-12 weeks
Finasteride in the treatment of men with androgenetic alopecia.
Journal of the American Academy of Dermatology (1998) · Rct · n=1553
Pivotal double-blind randomized, placebo-controlled trials of finasteride 1 mg/day for male pattern hair loss
Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
European journal of dermatology : EJD (2002) · Rct · n=1553
Five-year placebo-controlled extension of the pivotal Phase III hair-loss trials
The impact of monotherapies for male androgenetic alopecia: A network meta-analysis study.
Journal of cosmetic dermatology (2024) · Meta analysis
Network meta-analysis of monotherapies for male androgenetic alopecia
Cernilton for benign prostatic hyperplasia
Cochrane Database of Systematic Reviews (2000) · Systematic review · n=444
444 men were enrolled in 2 placebo-controlled and 2 comparative trials lasting from 12 to 24 weeks; three used a double-blind method although treatment allocation concealment was unclear in all.
A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study
European Urology (2009) · Rct · n=139
139 men with NIH category IIIA CP/CPPS were randomised to pollen extract (n=70) or placebo (n=69), dosed as two capsules every 8 hours for 12 weeks.
A systematic review of Cernilton for the treatment of benign prostatic hyperplasia
BJU International (2000) · Systematic review · n=444
444 men were enrolled in two placebo-controlled and two comparative trials lasting 12-24 weeks; concealment of treatment allocation was unclear in all.
Finasteride has a higher evidence score (5.5/10 vs 4.8/10) and wins in 2 of 3 categories.
For prostate health, Rye Pollen Extract has a higher relevance score (78 vs 75).
No known interactions between Finasteride and Rye Pollen Extract have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.